Weighted Average Number of Shares Outstanding, Diluted of Eloxx Pharmaceuticals, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Eloxx Pharmaceuticals, Inc. annual and quarterly Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Eloxx Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2023 was 2,570,620, a 19% increase year-over-year.
  • Eloxx Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 12,347,495, a 228% increase from 2024.
  • Eloxx Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 3,758,804, a 46% increase from 2023.
  • Eloxx Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2,570,620, a 19% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)

Eloxx Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 12,347,495 +8,588,691 +228% 01 Jan 2025 31 Dec 2025 10-K 17 Mar 2026 2025 FY
2024 3,758,804 +1,188,184 +46% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2026 2025 FY
2023 2,570,620 +404,309 +19% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2026 2025 FY
2022 2,166,311 +417,240 +24% 01 Jan 2022 31 Dec 2022 10-K 31 Mar 2023 2022 FY
2021 1,749,071 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY

Eloxx Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2023 2,570,620 +404,309 +19% 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2026 2025 FY
Q3 2023 2,747,687 +581,283 +27% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 2,212,364 +46,012 +2.1% 01 Apr 2023 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 2,166,356 +81 +0% 01 Jan 2023 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 2,166,311 01 Oct 2022 31 Dec 2022 10-K 31 Mar 2023 2022 FY
Q3 2022 2,166,404 -84,042,350 -97% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 2,166,352 -64,223,513 -97% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 2,166,275 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q3 2021 86,208,754 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 66,389,865 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.